Alessandra Valéria de Sousa Faria
State University of Campinas
20 Papers
15 Citations
Alessandra Valéria de Sousa Faria is an academic researcher from State University of Campinas. The author has contributed to research in topics: Cancer & Biology. The author has an hindex of 4, co-authored 14 publications. Previous affiliations of Alessandra Valéria de Sousa Faria include Erasmus University Medical Center.
Author Tools
Chat about Author
Papers
Action and function of Faecalibacterium prausnitzii in health and disease.
TL;DR: Counterbalancing dysbiosis using Faecalibacterium prausnitzii as a potential active component of probiotic formulations appears to be a promising therapeutic strategy for inflammatory bowel diseases and colorectal cancer.
386
Platelets in aging and cancer—“double-edged sword”
Alessandra Valéria de Sousa Faria,Alessandra Valéria de Sousa Faria,Sheila Siqueira Andrade,Maikel P. Peppelenbosch,Carmen Veríssima Ferreira-Halder,Gwenny M. Fuhler +5 more
TL;DR: The changes that occur in platelets during aging are reviewed, and how these versatile blood components contribute to cancer progression is investigated.
Platelets as a 'natural factory' for growth factor production that sustains normal (and pathological) cell biology.
Sheila Siqueira Andrade,Alessandra Valéria de Sousa Faria,Dagmar de Paulo Queluz,Carmen Veríssima Ferreira-Halder +3 more
TL;DR: By combining the platelets’ plasticity and biotechnological processes, PlateInnove Biotechnology optimized the production of GFs in nanoparticle biointerfacing by platelet content, which opens an avenue of possibilities.
8
Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ).
TL;DR: Novel aspects of Vemurafenib action in colorectal cancer can decrease the activity of protein tyrosine phosphatases (LMWPTP and PTP1B) and the TGFβ pathway, making them important in the CRC aggressiveness.
6